Home › Prescription medicine › Bionpharma Inc. — Atovaquone Oral Suspension,…
Bionpharma Inc. — Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
The Recall Registry rates this highest risk — FDA Class I: reasonable probability of serious harm or death.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Bionpharma Inc.
The product
Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Details
- Units affected
- 1,980 bottles
- Recall date
- September 17, 2024
- Brand
- Bionpharma Inc.
Nationwide in the U.S.A
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Bionpharma Inc. — Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine